Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons

Marco Peviani, Mami Kurosaki, Mineko Terao, Dario Lidonnici, Francesco Gensano, Elisa Battaglia, Massimo Tortarolo, Roberto Piva, Caterina Bendotti

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Recombinant lentiviral vectors (rLVs) have emerged as versatile tools for gene delivery applications due to a number of favorable features, such as the possibility to maintain long-term transgene expression, the flexibility in the design of the expression cassettes and recent improvements in their biosafety profile. Since rLVs are able to infect multiple cell types including post-mitotic cells such as neurons and skeletal muscle cells, several studies have been exploring their application for the study and cure of neurodegenerative diseases. In particular, the introduction of rLVs carrying cell-type specific promoters could restrict the transgene expression either to neuronal or glial cells, thus helping to better dissect in vivo the role played by these cell populations in several neurodegenerative processes. In this study we developed rLVs carrying motor neuron specific regulatory sequences derived from the promoter of homeobox gene Hb9, and demonstrated that these constructs can represent a suitable platform for selective gene-targeting of murine spinal cord motor neurons, in vivo. This tool could be instrumental in the dissection of the molecular mechanisms involved in the selective degeneration of motor neurons occurring in Motor Neuron Diseases.

Original languageEnglish
Pages (from-to)139-147
Number of pages9
JournalJournal of Neuroscience Methods
Volume205
Issue number1
DOIs
Publication statusPublished - Mar 30 2012

Fingerprint

Motor Neurons
Transgenes
Spinal Cord
Motor Neuron Disease
Gene Targeting
Homeobox Genes
Neuroglia
Neurodegenerative Diseases
Muscle Cells
Dissection
Skeletal Muscle
Neurons
Population
Genes

Keywords

  • Cell targeting
  • Motor neurons
  • Promoters
  • Viral vectors

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. / Peviani, Marco; Kurosaki, Mami; Terao, Mineko; Lidonnici, Dario; Gensano, Francesco; Battaglia, Elisa; Tortarolo, Massimo; Piva, Roberto; Bendotti, Caterina.

In: Journal of Neuroscience Methods, Vol. 205, No. 1, 30.03.2012, p. 139-147.

Research output: Contribution to journalArticle

Peviani, Marco ; Kurosaki, Mami ; Terao, Mineko ; Lidonnici, Dario ; Gensano, Francesco ; Battaglia, Elisa ; Tortarolo, Massimo ; Piva, Roberto ; Bendotti, Caterina. / Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons. In: Journal of Neuroscience Methods. 2012 ; Vol. 205, No. 1. pp. 139-147.
@article{ba60842c821c437bb9caa979ff657c2b,
title = "Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons",
abstract = "Recombinant lentiviral vectors (rLVs) have emerged as versatile tools for gene delivery applications due to a number of favorable features, such as the possibility to maintain long-term transgene expression, the flexibility in the design of the expression cassettes and recent improvements in their biosafety profile. Since rLVs are able to infect multiple cell types including post-mitotic cells such as neurons and skeletal muscle cells, several studies have been exploring their application for the study and cure of neurodegenerative diseases. In particular, the introduction of rLVs carrying cell-type specific promoters could restrict the transgene expression either to neuronal or glial cells, thus helping to better dissect in vivo the role played by these cell populations in several neurodegenerative processes. In this study we developed rLVs carrying motor neuron specific regulatory sequences derived from the promoter of homeobox gene Hb9, and demonstrated that these constructs can represent a suitable platform for selective gene-targeting of murine spinal cord motor neurons, in vivo. This tool could be instrumental in the dissection of the molecular mechanisms involved in the selective degeneration of motor neurons occurring in Motor Neuron Diseases.",
keywords = "Cell targeting, Motor neurons, Promoters, Viral vectors",
author = "Marco Peviani and Mami Kurosaki and Mineko Terao and Dario Lidonnici and Francesco Gensano and Elisa Battaglia and Massimo Tortarolo and Roberto Piva and Caterina Bendotti",
year = "2012",
month = "3",
day = "30",
doi = "10.1016/j.jneumeth.2011.12.024",
language = "English",
volume = "205",
pages = "139--147",
journal = "Journal of Neuroscience Methods",
issn = "0165-0270",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Lentiviral vectors carrying enhancer elements of Hb9 promoter drive selective transgene expression in mouse spinal cord motor neurons

AU - Peviani, Marco

AU - Kurosaki, Mami

AU - Terao, Mineko

AU - Lidonnici, Dario

AU - Gensano, Francesco

AU - Battaglia, Elisa

AU - Tortarolo, Massimo

AU - Piva, Roberto

AU - Bendotti, Caterina

PY - 2012/3/30

Y1 - 2012/3/30

N2 - Recombinant lentiviral vectors (rLVs) have emerged as versatile tools for gene delivery applications due to a number of favorable features, such as the possibility to maintain long-term transgene expression, the flexibility in the design of the expression cassettes and recent improvements in their biosafety profile. Since rLVs are able to infect multiple cell types including post-mitotic cells such as neurons and skeletal muscle cells, several studies have been exploring their application for the study and cure of neurodegenerative diseases. In particular, the introduction of rLVs carrying cell-type specific promoters could restrict the transgene expression either to neuronal or glial cells, thus helping to better dissect in vivo the role played by these cell populations in several neurodegenerative processes. In this study we developed rLVs carrying motor neuron specific regulatory sequences derived from the promoter of homeobox gene Hb9, and demonstrated that these constructs can represent a suitable platform for selective gene-targeting of murine spinal cord motor neurons, in vivo. This tool could be instrumental in the dissection of the molecular mechanisms involved in the selective degeneration of motor neurons occurring in Motor Neuron Diseases.

AB - Recombinant lentiviral vectors (rLVs) have emerged as versatile tools for gene delivery applications due to a number of favorable features, such as the possibility to maintain long-term transgene expression, the flexibility in the design of the expression cassettes and recent improvements in their biosafety profile. Since rLVs are able to infect multiple cell types including post-mitotic cells such as neurons and skeletal muscle cells, several studies have been exploring their application for the study and cure of neurodegenerative diseases. In particular, the introduction of rLVs carrying cell-type specific promoters could restrict the transgene expression either to neuronal or glial cells, thus helping to better dissect in vivo the role played by these cell populations in several neurodegenerative processes. In this study we developed rLVs carrying motor neuron specific regulatory sequences derived from the promoter of homeobox gene Hb9, and demonstrated that these constructs can represent a suitable platform for selective gene-targeting of murine spinal cord motor neurons, in vivo. This tool could be instrumental in the dissection of the molecular mechanisms involved in the selective degeneration of motor neurons occurring in Motor Neuron Diseases.

KW - Cell targeting

KW - Motor neurons

KW - Promoters

KW - Viral vectors

UR - http://www.scopus.com/inward/record.url?scp=84856064875&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84856064875&partnerID=8YFLogxK

U2 - 10.1016/j.jneumeth.2011.12.024

DO - 10.1016/j.jneumeth.2011.12.024

M3 - Article

C2 - 22245491

AN - SCOPUS:84856064875

VL - 205

SP - 139

EP - 147

JO - Journal of Neuroscience Methods

JF - Journal of Neuroscience Methods

SN - 0165-0270

IS - 1

ER -